Amkor Technology (AMKR)

NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-23

$39.30+0.64%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Amkor Technology’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+2.0%

+10% or more+5%0%−5%−10% or less

2.75 → 2.80 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	2.04B
EPS	—	0.773
FY 2026 · Annual
Revenue	—	7.66B
EPS	—	2.595
Capital expenditure	$2.5B–$3B	—
FY 2027 · Annual
Revenue	—	8.65B
EPS	—	2.801

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Manage capital with $2.75 billion capex in 2026 and maintain dividends	The company maintains steady dividends and invests in growth via $2.75 billion capex in 2026.	Broken	Capex falls below $2.5B or dividend per share drops below $0.08 in 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. The company increased its quarterly dividend from $0.08269 in 2025-Q4 to $0.08352 in 2026-Q1 and maintained this level in 2026-Q2. The Board also authorized a $300 million share repurchase in 2026-Q1. Dividend payments have been consistent and slightly increased, indicating delivery on this capital allocation priority. Delivery assessment Oct 24, 2026
EPS grows to at least $0.62 in Q3 2026	A supporting condition in Amkor Technology's published investment case. The stated target is >= $0.62 per share.	Intact	EPS falls below $0.57 in Q3 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Gross margin near 15% in Q2 2026	Revenue is expected near $1.8 billion next quarter with gross margin around 15%.	Under Pressure	Gross margin falls below 14.5% in Q2 2026	Gross margin: 16.79% FY2026-Q2; GAAP. Published target: ~15%. The target does not explicitly identify fiscal versus calendar quarters. Source published Jul 28, 202616.785873 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d8eee708-2966-4c78-b43b-432200731266. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue reaches at least $1.8 billion in Q2 2026	A primary condition in Amkor Technology's published investment case. The stated target is >= $1.8 billion.	Under Pressure	Revenue falls below $1.75 billion in Q2 2026	Revenue: $1.898B FY2026-Q2; GAAP. Published target: >= $1.8 billion. The target does not explicitly identify fiscal versus calendar quarters. Source published Jul 28, 20261,897,965,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d8eee708-2966-4c78-b43b-432200731266. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue increased from $1.511 billion in 2025-Q2 to $1.898 billion in 2026-Q2, a 25.5% growth. Management highlighted broad-based end market demand driving record revenue. The trajectory shows delivering consistent revenue growth aligned with management’s stated priority. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$2.80

$2.30 → $2.80 · observed estimates

FY2027 revenue$8.65B

$8.48B → $8.65B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$2.30	$8,484,054,450	7 / 9
2026-07-25	$2.57	$8,542,387,790	7 / 9
2026-07-26	$2.57	$8,542,387,790	7 / 9
2026-07-27	$2.46	$8,541,916,853	5 / 6
2026-07-28	$2.62	$8,590,120,600	7 / 9
2026-07-29	$2.86	$8,673,816,690	8 / 10
2026-07-30	$2.86	$8,673,816,690	8 / 10
2026-07-31	$2.82	$8,632,213,000	8 / 10
2026-08-01	$2.82	$8,632,213,000	8 / 10
2026-08-02	$2.82	$8,632,213,000	8 / 10
2026-08-03	$2.82	$8,632,213,000	8 / 10
2026-08-04	$2.82	$8,632,213,000	8 / 10
2026-08-05	$2.82	$8,632,213,000	8 / 10
2026-08-06	$2.82	$8,632,213,000	8 / 10
2026-08-07	$2.67	$8,581,075,919	6 / 7
2026-08-08	$2.82	$8,632,213,000	8 / 10
2026-08-09	$2.82	$8,632,213,000	8 / 10
2026-08-10	$2.82	$8,632,213,000	8 / 10
2026-08-11	$2.67	$8,581,075,919	6 / 7
2026-08-12	$2.82	$8,632,213,000	8 / 10
2026-08-13	$2.82	$8,632,213,000	8 / 10
2026-08-14	$2.67	$8,581,075,919	6 / 7
2026-08-15	$2.67	$8,581,075,919	6 / 7
2026-08-16	$2.67	$8,581,075,919	6 / 7
2026-08-17	$2.67	$8,581,075,919	6 / 7
2026-08-18	$2.67	$8,581,075,919	6 / 7
2026-08-19	$2.67	$8,581,075,919	6 / 7
2026-08-20	$2.67	$8,581,075,919	6 / 7
2026-08-21	$2.75	$8,614,409,252	6 / 7
2026-08-22	$2.75	$8,614,409,252	6 / 7
2026-08-23	$2.75	$8,614,409,252	6 / 7
2026-08-24	$2.75	$8,614,409,252	6 / 7
2026-08-25	$2.75	$8,614,409,252	6 / 7
2026-08-26	$2.75	$8,614,409,252	6 / 7
2026-08-27	$2.75	$8,614,409,252	6 / 7
2026-08-28	$2.75	$8,614,409,252	6 / 7
2026-08-29	$2.75	$8,622,978,821	6 / 8
2026-08-30	$2.75	$8,622,978,821	6 / 8
2026-08-31	$2.75	$8,622,978,821	7 / 8
2026-09-01	$2.75	$8,622,978,821	7 / 8
2026-09-02	$2.75	$8,622,978,821	7 / 8
2026-09-03	$2.75	$8,622,978,821	7 / 8
2026-09-04	$2.75	$8,622,978,821	7 / 8
2026-09-05	$2.75	$8,622,978,821	7 / 8
2026-09-06	$2.75	$8,622,978,821	7 / 8
2026-09-07	$2.75	$8,622,978,821	7 / 8
2026-09-08	$2.75	$8,622,978,821	7 / 8
2026-09-09	$2.75	$8,622,978,821	7 / 8
2026-09-10	$2.75	$8,622,978,821	7 / 8
2026-09-11	$2.75	$8,622,978,821	7 / 8
2026-09-12	$2.75	$8,622,978,821	7 / 8
2026-09-13	$2.75	$8,622,978,821	7 / 8
2026-09-14	$2.75	$8,622,978,821	7 / 8
2026-09-15	$2.75	$8,622,978,821	7 / 8
2026-09-16	$2.75	$8,622,978,821	7 / 8
2026-09-17	$2.75	$8,622,978,821	7 / 8
2026-09-18	$2.75	$8,622,978,821	7 / 8
2026-09-19	$2.75	$8,622,978,821	7 / 8
2026-09-20	$2.75	$8,622,978,821	7 / 8
2026-09-21	$2.75	$8,622,978,821	7 / 8
2026-09-22	$2.75	$8,622,978,821	7 / 8
2026-09-23	$2.75	$8,622,978,821	7 / 8
2026-09-24	$2.75	$8,622,978,821	7 / 8
2026-09-25	$2.75	$8,622,978,821	7 / 8
2026-09-26	$2.80	$8,637,393,723	7 / 8
2026-09-27	$2.80	$8,637,393,723	7 / 8
2026-09-28	$2.80	$8,637,393,723	7 / 8
2026-09-29	$2.80	$8,637,393,723	7 / 8
2026-09-30	$2.80	$8,637,393,723	7 / 8
2026-10-01	$2.80	$8,637,393,723	7 / 8
2026-10-02	$2.80	$8,637,393,723	7 / 8
2026-10-03	$2.80	$8,637,393,723	7 / 8
2026-10-04	$2.80	$8,637,393,723	7 / 8
2026-10-05	$2.80	$8,637,393,723	7 / 8
2026-10-06	$2.80	$8,637,393,723	7 / 8
2026-10-07	$2.80	$8,637,393,723	7 / 8
2026-10-08	$2.80	$8,637,393,723	7 / 8
2026-10-09	$2.80	$8,637,393,723	7 / 8
2026-10-10	$2.80	$8,637,393,723	7 / 8
2026-10-11	$2.80	$8,637,393,723	7 / 8
2026-10-12	$2.80	$8,637,393,723	7 / 8
2026-10-13	$2.80	$8,637,393,723	7 / 8
2026-10-14	$2.80	$8,637,393,723	7 / 8
2026-10-15	$2.80	$8,637,393,723	7 / 8
2026-10-16	$2.80	$8,637,393,723	7 / 8
2026-10-17	$2.80	$8,637,393,723	7 / 8
2026-10-18	$2.80	$8,637,393,723	7 / 8
2026-10-19	$2.80	$8,637,393,723	7 / 8
2026-10-20	$2.79	$8,640,460,390	7 / 8
2026-10-21	$2.79	$8,640,460,390	7 / 7
2026-10-22	$2.79	$8,640,452,057	7 / 8
2026-10-23	$2.80	$8,652,593,723	7 / 8
2026-10-24	$2.80	$8,652,593,723	7 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	5	5
2026-06-01	5	5
2026-07-01	6	5
2026-08-01	7	4
2026-09-01	7	4
2026-10-01	7	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Manage capital with $2.75 billion capex in 2026 and maintain dividendsPublished status: Broken
EPS grows to at least $0.62 in Q3 2026Direct metric needs a verified mapping
Gross margin near 15% in Q2 2026Published status: Under Pressure
Revenue reaches at least $1.8 billion in Q2 2026Published status: Under Pressure

Next proof point

Oct 26, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.4%Typical daily move · historical

Downside history

-58.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Amkor Technology outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

AMKR is a cyclical technology manufacturing business with a growth opportunity in advanced packaging and testing for AI, high-performance computing, and automotive markets. Its long-term thesis is intact, but confidence has eased from high to medium and the risk rating is high.

What's priced into Amkor Technology

The evidence labels AMKR cheap versus peers, while also showing a 36% premium versus peers and a negative expectations gap. The priced-in assessment is marked justified, with low fragility, so the snapshot does not point to unusually fragile expectations.

What the fundamentals likely do

Near-term results have been strong: quarterly revenue rose 12.6% from Q1 to Q2 2026, and gross margin improved from 14.2% to 16.8%. Management is on track with capacity expansion and partnership priorities, while capital spending progress is mixed; a guidance cut on the next call is a key near-term risk.

What Amkor Technology hinges on

Over the next few quarters, the thesis depends on continued execution in advanced packaging and testing and on whether capacity investment supports revenue and margin progress. A guidance cut would weaken the setup, while easier interest rates or continued strong results from major technology peers could support sector conditions.